AusCann Group Holdings Pty Ltd | Company
AusCann Group Holdings Pty Ltd
Reviews
to load big map
25.01.2022 AusCann ended the financial year making good progress towards our unique Australian pharmaceutical product & is targeting production of Australian pharmaceuticals in 2019 - Managing Director Elaine Darby | ASX announcement: http://ow.ly/agzd30lbZon
25.01.2022 AusCann Group Holdings (ASX:AC8) is delighted to attend FNNs Investor Event with Shaw and Partners today in Sydney | Pictured: Managing Director, Elaine Darby
24.01.2022 AusCann Group Holdings has commenced trading on the US OTCQX Market under the stock symbol ACNNF | ASX Announcement: http://ow.ly/qeXQ30lMyGD
23.01.2022 Our Chief Medical Advisor Dr Danial Schecter is presenting at the IV Seminario Internacional de Cannabis Medicinal Santiago de Chile - organised by our Chilean partner Fundacin Daya https://lnkd.in/gji_JgM
21.01.2022 Director of Business Development, Stewart Washer, will be speaking at CannaTech Sydney, Australias first ever global medical cannabis summit | Get your tickets here: https://t.co/9aSaSLtAZE
20.01.2022 The ASX Small and Mid-Cap Conference was on yesterday! Couldnt attend in-person? Watch our Managing Director Elaine discuss AusCann and Australias medical cannabis industry at the 3:22:54 hour mark: bddy.me/2MMD7S1
20.01.2022 New Media Watch Report - "Painful Confusion: How most Australia media outlets where duped on a study of Medical Cannabis" |AOD Media Watch reports: http://ow.ly/Wpxd30ldadg
19.01.2022 Watch AusCanns (ASX:AC8) Managing Director Elaine Darby discuss our company and Australias medicinal cannabis industry at ASX Small and Mid-Cap Conference | ASX Video: ow.ly/105A30lMF6R
19.01.2022 A behind the scenes image of Managing Director Elaine Darbys interview with Finance News Network where she discussed the companys final dose cannabinoid capsule study, 2018 crop yield, production and outlook | To watch the interview, click here: http://ow.ly/OhOT30lQoZP
19.01.2022 "The team has progressed really, really well in our development of a stable, standardised final dose form cannabinoid medicine." AusCanns MD, Elaine Darby, on the companys recent progress in creating cannabinoid medication | To watch the interview: http://ow.ly/40N330lbZs1
17.01.2022 Our Managing Director Elaine Darby presenting at Canaccord Genuitys 38th Annual Growth Conference in Boston 8 - 9 August 2018
17.01.2022 AusCann is pleased to provide results of its recent Share Purchase Plan | ASX announcement: https://www.asx.com.au/a/statistics/displayAnnouncement.do
17.01.2022 At day one of the Australian Microcap Investment Conference our Director of Business Development Stewart Washer presents how AusCann is aiming to become a leading supplier of cannabinoid pharmaceuticals
15.01.2022 Watch our Managing Director, Elaine Darby talks about the companys final dose cannabinoid capsule study, 2018 crop yields, production and outlook with Finance News Network | Link: http://ow.ly/PH5m30lNzT4
15.01.2022 A highly regarded scientific journal, The Lancet Public Health, questions the validity of reporting on observational studies involving uncontrolled dose/type and asks, Are we repeating previous mistakes in pain management? |The Lancet reports: http://ow.ly/YmAc30lek8u
15.01.2022 AusCanns joint venture DayaCann has just signed a MoU with Columbian Khiron Life Sciences http://goo.gl/w9hyQy #AC8 #ASX
15.01.2022 AusCann announces Leadership Transition and Board Appointment Links here: http://goo.gl/6AmVGr http://goo.gl/oCf4bE
15.01.2022 AusCann (ASX:AC8) believes Australian patients have the right to access high quality, cost effective, cannabinoid medicines | Pictured: Managing Director Elaine Darby at ASX Small & Mid-Cap Conference at the International Convention Centre | Learn more: auscann.com.au
15.01.2022 Released today our Annual Report 2018: Shaping the future of medicinal cannabis http://goo.gl/HvyRmD
14.01.2022 AusCann has completed a successful pilot study of an optimal final dose for its proprietary cannabinoid medicines | ASX announcement: http://ow.ly/ItDJ30lqiom
14.01.2022 Read about AusCann (ASX:AC8) in Canaccord Genuitys Australian Cannabis research report | Matthijs Smith reports: http://ow.ly/rqiU30lFD4b
14.01.2022 Elaine Darby and Stewart Washer presenting at leading conference CannaTech Sydney today.
12.01.2022 AusCann now added to the OTCQX Composite Index in latest US OTC Markets index rebalancing. https://bit.ly/2q1xOjE
12.01.2022 AusCannAU is pleased to advise the release of cannabinoid medical education resources for Australian health professionals. Available under the AusCann Medical Portal https://bit.ly/2P4ef5p
12.01.2022 Watch our Managing Director Elaine Darby talk to Proactive Investors Australia about how AusCann is targeting pain management with Australian cannabinoid products | Link: http://ow.ly/qM0s30lKlCc
11.01.2022 AusCann (ASX:AC8) is pleased to provide our its preliminary results for FY18 | ASX announcement: http://ow.ly/yDDs30lD3hd
11.01.2022 The inaugural ASX Small and Mid-Cap Conference is being held today at the International Convention Centre in Sydney featuring AusCanns Managing Director Elaine Darby (ASX:AC8)
11.01.2022 Chief Medical Advisor, Danial Schecter, will be speaking at CannaTech Sydney, Australia's first ever global medical cannabis summit CannaTech | Get your tickets here: http://goo.gl/dVWYsi
10.01.2022 "The inaugural ASX Small and Mid-Cap Conference will be held on Thursday 6 September 2018 in Sydney and showcase 21 emerging companies in the small and mid-cap category" - Featuring AusCann| Proactive Investors reports: http://ow.ly/hLXC30lAWam
09.01.2022 AusCann on track for launch of validated cannabinoid medicines in 2019. You can view our September Quarterly Activities Report here: http://goo.gl/Woz8u6
09.01.2022 The European Pain Federation (EFIC) has positioned a paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management | To read the paper: http://ow.ly/tF1L30ljpyr
07.01.2022 "Id like to personally thank all shareholders for their continued support and we look forward to delivering on our commitment to releasing our first medicinal cannabis products in 2019" Our Managing Director Elaine Darby | ASX announcement: http://ow.ly/356n30lD49W
07.01.2022 Watch Managing Director Elaine Darbys presentation at Finance News Networks Investor Event in Sydney where she discussed our final dose cannabinoid capsule study, 2018 crop yield, production and outlook | Link: http://ow.ly/UiI630lQoWF
06.01.2022 Chief Medical Advisor, Danial Schecter, will be speaking at CannaTech Sydney, Australias first ever global medical cannabis summit CannaTech | Get your tickets here: http://goo.gl/dVWYsi
03.01.2022 Managing Director, Elaine Darby, will be speaking at CannaTech Sydney, Australias first ever global medical cannabis summit | Get your tickets here: https://www.sydney.canna-tech.co/
02.01.2022 "OTC Markets Group Welcomes AusCann Group Holdings Ltd. to OTCQX" |Read announcement: http://ow.ly/OqWZ30lNDy9
02.01.2022 AusCanns Managing Director, Elaine Darby talks to Finance News Network about the companys recent capital raising, including progress locally and overseas with its production and medical program | To watch the interview: http://ow.ly/Q9H030lbZq3
